SRL
GPCR icon

Scientech Research LLC’s Structure Therapeutics GPCR Stock Holding History

Scientech Research LLC’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Buy
+6,958
New +$476K 0.28% 104
2024
Q3 		– Sell
-18,803
Closed -$738K – 698
2024
Q2 		$738K Buy
+18,803
New +$772K 0.15% 245

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Scientech Research LLC's GPCR Position: Q1 2026 in Review

Scientech Research LLC opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 6,958 shares worth $335K. The stake represents 0.28% of the portfolio and ranks #104 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in GPCR as recently as Q2 2024.

Scientech Research LLC first reported a position in GPCR in Q2 2024 and has held it in 2 quarters since. The position peaked at $738K in Q2 2024. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Scientech Research LLC held 6,958 shares of Structure Therapeutics worth $335K as of Q1 2026.
  • Structure Therapeutics was a new Scientech Research LLC position in Q1 2026.
  • Structure Therapeutics made up 0.28% of Scientech Research LLC's portfolio in Q1 2026, its #104 holding.
  • Scientech Research LLC first reported a position in Structure Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • Scientech Research LLC's Structure Therapeutics position peaked at $738K in Q2 2024.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.